- JP-listed companies
- SAWAI GROUP HOLDINGS Co., Ltd.
- Financials
- Net income margin (%)
SAWAI GROUP HOLDINGS Co., Ltd. (4887)
Market cap
¥296.5B
P/E ratio
18.6x
Sawai Group Holdings manufactures and sells prescription and over-the-counter pharmaceuticals through its domestic subsidiaries in Japan.
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 6.3 | -18.23% |
| Mar 31, 2024 | 7.7 | +22.47% |
| Mar 31, 2023 | 6.3 | -143.35% |
| Mar 31, 2022 | -14.6 |